Gross Profit (TTM) Chart

Historical Gross Profit (TTM) Data

View and export this data back to 2001. Start Trial.
Date Value
September 30, 2026 3.951B
June 30, 2026 3.839B
March 31, 2026 3.650B
December 31, 2025 3.489B
September 30, 2025 3.386B
June 30, 2025 3.202B
March 31, 2025 3.074B
December 31, 2024 2.977B
September 30, 2024 2.760B
June 30, 2024 2.661B
March 31, 2024 2.515B
December 31, 2023 1.939B
September 30, 2023 1.282B
June 30, 2023 605.99M
March 31, 2023 0.00
December 31, 2022 0.00
September 30, 2022 0.00
June 30, 2022 0.00
March 31, 2022 0.00
December 31, 2021 0.00
September 30, 2021 0.00
June 30, 2021 0.00
March 31, 2021 0.00
December 31, 2020 0.00
September 30, 2020 0.00
Date Value
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 0.00
September 30, 2019 0.00
June 30, 2019 0.00
March 31, 2019 0.00
December 31, 2018 0.00
September 30, 2018 0.00
June 30, 2018 0.00
March 31, 2018 0.00
December 31, 2017 0.00
September 30, 2017 0.00
June 30, 2017 0.00
March 31, 2017 0.00
December 31, 2016 0.00
September 30, 2016 0.00
June 30, 2016 0.00
March 31, 2016 0.00
December 31, 2015 0.00
September 30, 2015 0.00
June 30, 2015 0.00
March 31, 2015 0.00
December 31, 2014 0.00
September 30, 2014 39.43M
June 30, 2014 39.43M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
AbbVie, Inc. 48.66B
Incyte Corp. 5.502B
Ascendis Pharma A/S 1.265B
Zealand Pharma A/S 709.03M
Bavarian Nordic A/S 489.20M